新化股份(603867.SH):上半年淨利潤1.47億元,同比增長6.70%
格隆匯8月14日丨新化股份(603867.SH)公佈2024年半年度報吿,報吿期實現營業收入14.83億元,同比增長17.92%;歸屬於上市公司股東的淨利潤1.47億元,同比增長6.70%;歸屬於上市公司股東的扣除非經常性損益的淨利潤1.41億元,同比增長5.94%;基本每股收益0.80元。
公司主要產品低碳脂肪胺、有機溶劑、合成香料,都屬於精細化工行業,公司主要產品的裝置規模和工藝技術等在國內具有較強的競爭優勢。主導產品異丙胺、乙基胺和異丙醇無論從生產規模、成本、市場佔有率來説,都具有較強的競爭優勢。作為國內脂肪胺行業重要生產企業,公司的綜合產能位居國內前列,系目前全球範圍內排名前列的低碳脂肪胺產品生產企業。其中:公司現有異丙胺產能國內最大,曾入選工業和信息化部第三批製造業單項冠軍產品。公司通過了ISO9001質量管理體系、ISO14001環境管理體系、GB/T28001職業健康安全管理體系認證,產品質量優異,為國內眾多醫藥企業的合格供應商。其中:工業用一異丙胺、工業用三乙胺、工業用一正丁胺三個產品獲“浙江製造”認證。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.